© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Tango Therapeutics, Inc. (TNGX) shows an Average True Range (ATR) of 0.57 and an Enterprise Value of 800.67M. Its average trading volume over the past 3 months is 3.16M, indicating liquidity. These fundamental metrics provide insight into TNGX's underlying financial health and market activity.
Tango Therapeutics, Inc. (TNGX) technical indicators as of December 31, 2025: the SMA 20 is -4.78%, SMA 50 at -1.49%, and SMA 200 at 50.44%. The RSI 14 value is 44.65, suggesting its current momentum. These technical analysis signals help assess TNGX's price trends and potential future movements.
Tango Therapeutics, Inc. (TNGX) stock performance overview as of December 31, 2025: The 52-week high is $11.2 (currently -22.95% below), and the 52-week low is $1.03 (currently 737.86% above). Over the past year, TNGX's performance is 167.18%, compared to the S&P 500's 11.81% change.
According to market data, Tango Therapeutics, Inc. (TNGX) stock's recent performance metrics show that over the last month, TNGX is -19.8%, with a Year-to-Date (YTD) performance of 179.29%. Over the past year, the stock has seen a 167.18% change. These figures summarize TNGX's price movements across various periods, reflecting its historical returns.
According to current financial data, TNGX stock's P/E (TTM) ratio is -9.57, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for TNGX, including P/S (14.40), P/B (6.01), and P/FCF (-6.53), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.